SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-21-007146
Filing Date
2021-02-05
Accepted
2021-02-05 17:04:37
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q f10q0920a1_180lifescienceco.htm 10-Q/A 520254
2 CERTIFICATION f10q0920a1ex31-1_180lifesci.htm EX-31.1 9381
3 CERTIFICATION f10q0920a1ex31-2_180lifesci.htm EX-31.2 9418
4 CERTIFICATION f10q0920a1ex32-1_180lifesci.htm EX-32.1 5213
  Complete submission text file 0001213900-21-007146.txt   4583371

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE atnf-20200930.xml EX-101.INS 749229
6 XBRL SCHEMA FILE atnf-20200930.xsd EX-101.SCH 63833
7 XBRL CALCULATION FILE atnf-20200930_cal.xml EX-101.CAL 51222
8 XBRL DEFINITION FILE atnf-20200930_def.xml EX-101.DEF 263946
9 XBRL LABEL FILE atnf-20200930_lab.xml EX-101.LAB 337597
10 XBRL PRESENTATION FILE atnf-20200930_pre.xml EX-101.PRE 344161
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38105 | Film No.: 21597004
SIC: 2834 Pharmaceutical Preparations